Increased expression of renal cyclooxygenase-2 and neuronal nitric oxide synthase in hypertensive Cx40-deficient mice

Journal of Vascular Research

Volumn 46, Issue 3, 2009, Pages 188-198

  Krattinger, Nathalie ^a   Alonso, Florian ^a   Capponi, Alessandro ^b   Mazzolai, Lucia ^a   Nicod, Pascal ^a   Meda, Paolo ^b   Haefliger, Jacques Antoine ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Connexins; Gap junctions; Hypertension; Kidney; Secretion; Transgenic mice

Indexed keywords

ANGIOTENSIN II; CANDESARTAN; CILETEXIL; CONNEXIN 40; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENZYME; INDOMETACIN; MESSENGER RNA; N(G) NITROARGININE METHYL ESTER; NEURONAL NITRIC OXIDE SYNTHASE; RENIN; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; CLINICAL EVALUATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; HYPERTENSION; KIDNEY; KIDNEY PERFUSION; MACULA DENSA; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENIN RELEASE; VASOCONSTRICTION; WILD TYPE;

ANIMALS; BLOOD PRESSURE; CONNEXINS; CYCLOOXYGENASE 2; HYPERTENSION; KIDNEY; MICE; MICE, INBRED C57BL; NITRIC OXIDE SYNTHASE TYPE I; PROSTAGLANDIN ANTAGONISTS; RENIN; RNA, MESSENGER;

EID: 52149121830     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000156704     Document Type: Article

References (56)

1. Harris RC: Cox-2 and the kidney. J Cardiovasc Pharmacol 2006;47(suppl 1):S37-S42.
2. Harris RC, Zhang MZ, Cheng HF: Cyclooxygenase-2 and the renal renin-angiotensin system. Acta Physiol Scand 2004;181:543-547.
3. Hartner A, Cordasic N, Goppelt-Struebe M, Veelken R, Hilgers KF: Role of macula densa cyclooxygenase-2 in renovascular hypertension. Am J Physiol Renal Physiol 2003;284:F498-F502.
4. Nasrallah R, Hebert RL: Prostacyclin signaling in the kidney: implications for health and disease. Am J Physiol Renal Physiol 2005;289:F235-F246.
5. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD: Cyclooxygenase-2 is associated with the macula densa of rat kidney and increases with salt restriction. J Clin Invest 1994;94:2504-2510.
6. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD: Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 2002;110:61-69.
7. Wagner C, Vitzthum H, Castrop H, Schumacher K, Bucher M, Albertin S, Coffman TM, Arendshorst WJ, Kurtz A: Differential regulation of renin and Cox-2 expression in the renal cortex of c57Bl/6 mice. Pflügers Arch 2003;447:214-222.
8. Harris RC, Breyer MD: Physiological regulation of cyclooxygenase-2 in the kidney. Am J Physiol Renal Physiol 2001;281:F1-F11.
9. Höcherl K, Wolf K, Castrop H, Ittner KP, Bucher M, Kees F, Grobecker HF, Kurtz A: Renocortical expression of renin and of cyclooxygenase-2 in response to angiotensin II AT1 receptor blockade is closely coordinated but not causally linked. Pflügers Arch 2001;442:821-827.
10. Castrop H, Klar J, Wagner C, Höcherl K, Kurtz A: General inhibition of renocortical cyclooxygenase-2 expression by the renin-angiotensin system. Am J Physiol Renal Physiol 2003;284:F518-F524.
11. Höcherl K, Kammerl MC, Schumacher K, Endemann D, Grobecker HF, Kurtz A: Role of prostanoids in regulation of the renin-angiotensin-aldosterone system by salt intake. Am J Physiol Renal Physiol 2002;283:F294-F301.
12. Mann B, Hartner A, Jensen BL, Hilgers KF, Höcherl K, Krämer BK, Kurtz A: Acute up-regulation of COX-2 by renal artery stenosis. Am J Physiol Renal Physiol 2001;280:F119-F125.
13. Schricker K, Hamann M, Kurtz A: Nitric oxide and prostaglandins are involved in the macula densa control of the renin system. Am J Physiol 1995;269:F825-F830.
14. Cheng HF, Wang JL, Zhang MZ, McKanna JA, Harris RC: Nitric oxide regulates renal cortical cyclooxygenase-2 expression. Am J Physiol Renal Physiol 2000;279:F122-F129.
15. Cheng EY, Decker RS, Lee C: Role of angiotensin II in bladder smooth muscle growth and function. Adv Exp Med Biol 1999;462:183-191.
16. Schricker K, Potzl B, Hamann M, Kurtz A: Coordinate changes of renin and brain-type nitric-oxide-synthase (b-NOS) mRNA levels in rat kidneys. Pflügers Arch 1996;432:394-400.
17. Wolf K, Castrop H, Hartner A, Goppelt-Strube M, Hilgers KF, Kurtz A: Inhibition of the renin-angiotensin system upregulates cyclooxygenase-2 expression in the macula densa. Hypertension 1999;34:503-507.
18. Yang T, Singh I, Pham H, Sun D, Smart A, Schnermann JB, Briggs JP: Regulation of cyclooxygenase expression in the kidney by dietary salt intake. Am J Physiol 1998;274:F481-F489.
19. Castrop H, Kammerl M, Mann B, Jensen BL, Krämer BK, Kurtz A: Cyclooxygenase 2 and neuronal nitric oxide synthase expression in the renal cortex are not interdependent in states of salt deficiency. Pflügers Arch 2000;441:235-240.
20. Schweda F, Friis U, Wagner C, Skott O, Kurtz A: Renin release. Physiology (Bethesda) 2007;22:310-319.
21. Schweda F, Kurtz A: Cellular mechanism of renin release. Acta Physiol Scand 2004;181:383-390.
22. Mullins LJ, Bailey MA, Mullins JJ: Hypertension, kidney, and transgenics: a fresh perspective. Physiol Rev 2006;86:709-746.
23. Haefliger JA, Demotz S, Braissant O, Suter E, Waeber B, Nicod P, Meda P: Connexins 40 and 43 are differentially regulated within the kidneys of rats with renovascular hypertension. Kidney Int 2001;60:190-201.
24. Haefliger JA, Nicod P, Meda P: Contribution of connexins to the function of the vascular wall. Cardiovasc Res 2004;62:345-356.
25. Sohl G, Willecke K: Gap junctions and the connexin protein family. Cardiovasc Res 2004;62:228-232.
26. 2+ and insulin oscillations, and basal insulin release. Diabetes 2005;54:1798-1807.
27. Klee P, Boucard N, Caille D, Cancela J, Charollais A, Charpentier E, Michon L, Populaire C, Peyrou M, Nlend Nlend R, Zuliano L, Haefliger J-A, Meda P: Connexin modulators of endocrine function;in Winterhager E (ed): Gap Junctions in Development and Disease. Berlin, Springer, 2005, pp 197-221.
28. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC: Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev 2003;83:1359-1400.
29. Zhang J, Hill CE: Differential connexin expression in preglomerular and postglomerular vasculature: Accentuation during diabetes. Kidney Int 2005;68:1171-1185.
30. Haefliger JA, Krattinger N, Martin D, Pedrazzini T, Capponi A, Doring B, Plum A, Charollais A, Willecke K, Meda P: Connexin43-dependent mechanism modulates renin secretion and hypertension. J Clin Invest 2006;116:405-413.
31. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K: Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin40-deficient mice. Curr Biol 1998;8:299-302.
32. Simon AM, Goodenough DA, Paul DL: Mice lacking connexin40 have cardiac conduction abnormalities characteristic of atrioventricular block and bundle branch block. Curr Biol 1998;8:295-298.
33. de Wit C, Roos F, Bolz SS, Kirchhoff S, Kruger O, Willecke K, Pohl U: Impaired conduction of vasodilation along arterioles in connexin40-deficient mice. Circ Res 2000;86:649-655.
34. de Wit C, Roos F, Bolz SS, Pohl U: Lack of vascular connexin 40 is associated with hypertension and irregular arteriolar vasomotion. Physiol Gen 2003;13:169-177.
35. Kurtz L, Schweda F, de Wit C, Kriz W, Witzgall R, Warth R, Sauter A, Kurtz A, Wagner C: Lack of connexin 40 causes displacement of renin-producing cells from afferent arterioles to the extraglomerular mesangium. J Am Soc Nephrol 2007;18:1103-1111.
36. Wagner C, de Wit C, Kurtz L, Grunberger C, Kurtz A, Schweda F: Connexin40 is essential for the pressure control of renin synthesis and secretion. Circ Res 2007;100:556-563.
37. Krattinger N, Capponi A, Mazzolai L, Aubert JF, Caille D, Nicod P, Waeber G, Meda P, Haefliger JA: Connexin40 regulates renin production and blood pressure. Kidney Int 2007;72:814-822.
38. Wagner C: Function of connexins in the renal circulation. Kidney Int 2008;73:547-555.
39. Gross V, Obst M, Kiss E, Janke J, Mazak I, Shagdarsuren E, Muller DN, Langenickel TH, Grone HJ, Luft FC: Cardiac hypertrophy and fibrosis in chronic L-NAME-treated AT2 receptor-deficient mice. J Hypertens 2004;22:997-1005.
40. Okazaki H, Minamino T, Tsukamoto O, Kim J, Okada K, Myoishi M, Wakeno M, Takashima S, Mochizuki N, Kitakaze M: Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition. Hypertens Res 2006;29:277-284.
41. Wiesel P, Mazzolai L, Nussberger J, Pedrazzini T: Two-kidney, one clip and one-kidney, one clip hypertension in mice. Hypertension 1997;29:1025-1030.
42. Haefliger JA, Polikar R, Schnyder G, Burdet M, Sutter E, Pexieder T, Nicod P, Meda P: Connexin37 in normal and pathological development of mouse heart and great arteries. Dev Dyn 2000;218:331-344.
43. Schricker K, Hamann M, Kurtz A: Prostaglandins are involved in the stimulation of renin gene expression in 2 kidney-1 clip rats. Pflügers Arch 1995;430:188-194.
44. Wagner C, de Wit C, Gerl M, Kurtz A, Höcherl K: Increased expression of cyclooxygenase 2 contributes to aberrant renin production in connexin 40-deficient kidneys. Am J Physiol Regul Integr Comp Physiol 2007;293:R1781-R1786.
45. Schricker K, Hegyi I, Hamann M, Kaissling B, Kurtz A: Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II. Proc Natl Acad Sci USA 1995;92:8006-8010.
46. Castrop H, Schweda F, Mizel D, Huang Y, Briggs J, Kurtz A, Schnermann J: Permissive role of nitric oxide in macula densa control of renin secretion. Am J Physiol Renal Physiol 2004;286:F848-F857.
47. Tojo A, Onozato ML, Fujita T: Role of macula densa neuronal nitric oxide synthase in renal diseases. Med Mol Morphol 2006;39:2-7.
48. de Wit C, Jahrbeck B, Schafer C, Bolz SS, Pohl U: Nitric oxide opposes myogenic pressure responses predominantly in large arterioles in vivo. Hypertension 1998;31:787-794.
49. Sigmon DH, Beierwaltes WH: Renal nitric oxide and angiotensin II interaction in renovascular hypertension. Hypertension 1993;22:237-242.
50. Sigmon DH, Beierwaltes WH: Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension. Hypertension 1998;31:649-656.
51. Mount PF, Power DA: Nitric oxide in the kidney: Functions and regulation of synthesis. Acta Physiol (Oxf) 2006;187:433-446.
52. Schnermann J, Traynor T, Yang T, Arend L, Huang YG, Smart A, Briggs JP: Tubuloglomerular feedback: new concepts and developments. Kidney Int Suppl 1998;67:S40-S45.
53. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of the renal microcirculation. Physiol Rev 1996;76:425-536.
54. Liu R, Persson AE: Angiotensin II stimulates calcium and nitric oxide release from macula densa cells through AT1 receptors. Hypertension 2004;43:649-653.
55. Schricker K, Kurtz A: Liberators of NO exert a dual effect on renin secretion from isolated mouse renal juxtaglomerular cells. Am J Physiol 1993;265:F180-F186.
56. Harrison-Bernard LM, Navar LG, Ho MM, Vinson GP, el-Dahr SS: Immunohistochemical localization of Ang II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 1997;273:F170-F177.